Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Alfred J Tector"'
Publikováno v:
Kidney360. 4:278-284
Autor:
Cynthia P. Breeden, Jose L. Estrada, Andrew B. Adams, Alfred J. Tector, Luz M. Reyes, Christopher Burlak, Brendan P. Lovasik, Matthew Tector, David A. Faber, Rodrigo M. Vianna
Publikováno v:
Ann Surg
OBJECTIVE Pig-to-primate renal xenotransplantation is plagued by early antibody-mediated graft loss which precludes clinical application of renal xenotransplantation. We evaluated whether temporary complement inhibition with anti-C5 antibody Tesidolu
Publikováno v:
Endocrine Practice. 12:545-551
Objective To present a case that demonstrates the evolution of a pheochromocytoma over a several-year period and to emphasize the importance of a thorough work-up for pheochromocytoma in patients with neurofibromatosis type 1 (NF1) and hypertension.
Autor:
Alan J. Moskowitz, Alfred J. Tector, William L. Holman, Walter P. Dembitsky, Edward Raines, Annetine C. Gelijns, Satoshi Furukawa, Soon J. Park, Eric A. Rose, William Piccioni, O. Howard Frazier
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 129:9-17
Objective The REMATCH trial compared the use of left ventricular assist devices with optimal medical management for patients with end-stage heart failure. When the trial met its primary end point criteria in July 2001, left ventricular assist device
Autor:
Satoshi Furukawa, Alfred J. Tector, Walter P. Dembitsky, Laura Damme, Gerald Heatley, Nuala S. Ronan, Alan D. Weinberg, William Piccione, James W. Long, Annetine C. Gelijns, Soon J. Park, William L. Holman, Victor Poirier, Alan J. Moskowitz
Publikováno v:
The Annals of Thoracic Surgery. 78:2123-2130
Background Left ventricular assist device (LVAD) failure and malfunction rates are critical gauges for establishing LVADs as a long-term therapy for end-stage heart failure patients. These device performance measures, however, have been inadequately
Autor:
O.H. Frazier, Yoshifumi Naka, T.B. Icenogle, Victor Poirier, Robert D. Dowling, Soon J. Park, Francis D. Pagani, Alfred J. Tector
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 25:958-963
Objective: The HeartMate® VE left ventricular assist system (LVAS) has supported more than 2300 patients and has been shown to be effective for bridge to cardiac transplantation and has demonstrated improved outcomes in survival as a destination the
Publikováno v:
The Annals of Thoracic Surgery. 72:450-455
Background . Most of our patients with coronary artery disease have undergone bypass exclusively with purely internal thoracic artery grafts (PITA). Our goal has been to lengthen the time a patient benefits from coronary bypass operations. The presen
Publikováno v:
Cellular Immunology. 201:144-153
CTLA-4 is an immunoregulatory receptor expressed on the surface of activated T and B lymphocytes. The counterreceptors for CTLA-4 are the B7 family molecules. We describe alternatively spliced mRNAs expressed in hematolymphoid tissues of humans, mice
Autor:
Terence M. Schmahl, Kurt A. Dasse, David C. Kress, Francis X Downey, Victor L. Poirier, Alfred J. Tector
Publikováno v:
The Annals of Thoracic Surgery. 65:643-646
Background . Safe transition from cardiopulmonary bypass to the HeartMate left ventricular assist device without periods of low output, air emboli, or injury to the right ventricle is vital to its successful implantation. A right atrial-to-left ventr